Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Long Term Debt 2013–2025
Viridian Therapeutics Inc. annual long term debt history from 2017 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Viridian Therapeutics Inc. long term debt as of December 31, 2024: 20.6M, a 1.87% increase year-over-year.
- Viridian Therapeutics Inc. long term debt for 2024 were 20.6M, a 1.87% increase from 2023.
- Viridian Therapeutics Inc. long term debt for 2023 were 20.2M, a 334.98% increase from 2022.
- Viridian Therapeutics Inc. long term debt for 2022 were 4.6M, a 39.42% decrease from 2019.
- Viridian Therapeutics Inc. long term debt for 2019 were 7.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Viridian Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $21 |
| 2023 | $20 |
| 2022 | $5 |
| 2019 | $8 |
| 2018 | $10 |
| 2017 | $10 |
Viridian Therapeutics Inc. Long Term Debt — FAQ
Viridian Therapeutics Inc. (VRDN) long term debt over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's long term debt history?
The chart and table above show Viridian Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.